Hepatocellular Cancer
New hepatocellular cancer research reported from Yonsei University
Published in Drug Law Weekly, August 11th, 2009
In this recently published article, scientists in Seoul, South Korea conducted a study "To investigate the additional value of diffusion-weighted imaging (DWI) in the MRI assessment of perilesionally recurrent hepatocellular carcinomas (HCCs) after transcatheter arterial chemoembolization (TACE). For gadopentetate dimeglumine-enhanced, multiphasic dynamic images with precontrast T1- and T2-weighted images of 23 patients treated with TACE, two radiologists independently sorted the confidence levels for the presence of a viable tumor in the vicinity of the treated lesions into five grades."
"In another session, images from DWI (b factor = 50, 400, and 866 s/mm(2)) were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-08-11)
More Articles from Drug Law Weekly
- Autism
Judge Sues Blue Cross for Autism Treatment - BioScrip, Inc.
BioScrip to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference - Biotechnology Business
Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 - Breast Cancer
Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin - Clinical Trial Research
Clinical Trial by Licensee Does Not Meet Primary Endpoint - Colon Cancer
Patient Advocacy Groups Urge Congress and President to Preserve Access to Medical Imaging - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
